CASI Pharmaceuticals (CASIF) Total Non-Current Liabilities (2021 - 2026)
CASI Pharmaceuticals (CASIF) recorded Total Non-Current Liabilities of $66.62 million in Q2 2026, up 76.5% from $37.74 million a year earlier.
Powered by 
Analysis
CASI Pharmaceuticals (CASIF) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends
At the end of FY2025, CASI Pharmaceuticals reported Total Non-Current Liabilities of $49.67 million, up 36.3% from FY2024.
- Annual Total Non-Current Liabilities has a four-year compound annual growth rate of 5.9% (FY2021 to FY2025).
- Across earlier years, Total Non-Current Liabilities came in at $36.45 million in FY2024 (+2.3%), $35.62 million in FY2023 (-9.5%), $39.36 million in FY2022 (-0.3%) and $39.47 million in FY2021.
- The Q2 2026 figure is the highest quarterly Total Non-Current Liabilities in data going back to Q4 2021.
- Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 76.5% in Q2 2026, against a decline of 26.0% in Q1 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 60.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 102.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 117.60 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 79.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -36.84 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 76.12 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 36.05 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 96.04 Bn |
| 10 | CASI Pharmaceuticals | 2.06 Mn | -18.77 Mn | - | 66.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 66.62 Mn |
| Dec 31, 2025 | 49.67 Mn |
| Sep 30, 2025 | 39.42 Mn |
| Jun 30, 2025 | 37.74 Mn |
| Mar 31, 2025 | 33.71 Mn |
| Dec 31, 2024 | 36.45 Mn |
| Sep 30, 2024 | 33.86 Mn |
| Jun 30, 2024 | 28.05 Mn |
| Mar 31, 2024 | 27.13 Mn |
| Dec 31, 2023 | 35.62 Mn |
| Sep 30, 2023 | 33.47 Mn |
| Jun 30, 2023 | 33.52 Mn |
| Mar 31, 2023 | 36.68 Mn |
| Dec 31, 2022 | 39.36 Mn |
| Dec 31, 2021 | 39.47 Mn |
API Access
CASI Pharmaceuticals Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CASIF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "CASIF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CASIF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();